A Trial of Prednisolone in Combination With SPI-62 or Placebo in Subjects With Polymyalgia Rheumatica (PMR)

NCT05436652 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

66

Enrollment

INDUSTRY

Sponsor class

Conditions

Polymyalgia Rheumatica

Interventions

DRUG: SPI-62
DRUG: SPI-62 matched placebo
DRUG: Prednisolone 10mg
DRUG: Additional prednisolone
DRUG: Additional prednisolone matched placebo

Sponsor

Sparrow Pharmaceuticals